1. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom / pod red. I. I. Dedova, M. V. Shestakovoi, A. Yu. Maiorova. 8-i vyp. // Sakhar. diab. - 2017. - № 20 (1S). - S. 1-112. doi: 10.14341/DM20171S8. [Algoritmy spetsial’zirovannoi pomoshchi bol’nym sakharnym diabetom. Diabetes mellitus. 2017;20(1S):1-112 (In Russ.)].
2. Malakhova Z. L., Vasina E. Yu., Vlasov T. D. Endotelii-zavisimaya vazodilatatsiya sosudov kozhi zdorovogo cheloveka: oksid azota ili giperpolyarizuyushchii faktor? // Ross. fiziolog. zhurn. im. I. M. Sechenova. - 2017. - T. 103. - № 8. - S. 930-939. [Malakhova ZL, Vasina EYu, Vlasov TD. Endothelium-dependent vasodilation of the skin of a healthy man: nitrogen oxide or hyperpolarizing factor? Neuroscience and behavioral physiology. 2017;103(8):930-939 (In Russ.)].
3. Malakhova Z. L., Vasina E. Yu., Vorob'ev E. A. i dr. Neinvazivnyi metod issledovaniya endotelial'nogo giperpolyarizuyushchego faktora v klinike // Regionarnoe krovoobrashchenie i mikrotsirkulyatsiya. - 2013. - T. 12. - № 4 (48). - S. 70-74. [Malakhova ZL, Vasina EYu, Vorobiev EA, et al. Non-invasive method of assessment of endothelium-derived hyperpolarizing factor in human. Regional hemodynamics and microcirculation. 2013;12:4(48):70-74 (In Russ.)].
4. Simanenkova A. V., Makarova M. N., Butomo M. I. i dr. Endotelioprotektivnyi effekt liraglutida u bol'nykh sakharnym diabetom 2-go tipa // Arterial'naya gipertenziya. - 2018. - T. 24. - № 1. - S. 81-92. doi: 10.18705/1607-419X-2018-24-1-81-92. [Simanenkova AV, Makarova MN, Butomo MI, et al. Endothelial protective effect of liraglutide in type 2 diabetes mellitus. Arterial Hypertension. 2018;24(1):81-92 (In Russ.)].
5. Simanenkova A. V., Makarova M. N., Vasina L. V. i dr. Agonist retseptora glyukagonopodobnogo peptida-1 umen'shaet disfunktsiyu endoteliya u bol'nykh sakharnym diabetom 2-go tipa // Regionarnoe krovoobrashchenie i mikrotsirkulyatsiya. - 2018. - T. 17. - № 2. - S. 59-65. [Simanenkova AV, Makarova MN, Vasina LV, et al. Glucagon-like peptide-1 receptor agonist diminishes endothelial dysfunction in type 2 diabetic patients. Regional hemodynamics and microcirculation. 2018;17(2):59-65 (In Russ.)].